Form 4: Intuitive Surgical EVP Myriam Curet Reports Stock Transactions
SEC Form 4
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports multiple transactions involving common stock and restricted stock units, including acquisitions, disposals, and vesting.
Summary
- Myriam Curet, an EVP & Chief Medical Officer at Intuitive Surgical, filed a Form 4 detailing changes in beneficial ownership.
- On February 27, 2025, performance goals were certified under performance stock units (PSUs), resulting in the acquisition of 5,012 shares.
- On February 28, 2025, 1,002 Restricted Stock Units (RSUs) vested and converted into common stock, with a portion of shares withheld for taxes.
- Also on February 28, 2025, 497 and 2,486 shares were disposed of to cover tax obligations related to RSU vesting and PSU settlement, respectively, at a price of $563.77 per share.
- On March 3, 2025, 3,031 shares were sold at a weighted average price of $577.2955, with prices ranging from $573.78 to $582.10, under a pre-arranged trading plan (Rule 10b5-1).
- Following these transactions, Curet directly owns 353 shares of common stock and 1,002 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about an executive's trading activity.
Future Outlook
The reporting person has a trading plan in place that expires on August 13, 2025, suggesting potential future transactions.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their sentiment towards the company's stock.
Stakeholder Impact
- Shareholders can use this information to understand the trading activity of a key executive.
- The transactions may have a minor impact on the stock price due to the volume of shares traded.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Certification of performance goals under performance stock units (PSUs), resulting in the acquisition of 5,012 shares. |
| 02/28/2025 | Restricted Stock Units (RSUs) vest and convert into common stock; shares withheld for taxes. |
| 02/28/2026 | Expiration date of the Restricted Stock Units. |
| 03/03/2025 | Sale of 3,031 shares under a pre-arranged trading plan (Rule 10b5-1). |
| 08/13/2025 | Expiration date of the Trading Plan that complies with SEC Rule 10b5-1. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.